Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-09-24A Phase IA/IB Trial of PTX-200 and Carboplatin in Patients With Platinum-Resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-09-17A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus
-
CLINICAL_TRIALS study record update · 2020-09-14A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP Inhibitor) in Subjects With Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2020-09-10Study of Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer (Ovarian Spore)
-
CLINICAL_TRIALS study record update · 2020-09-10Extended Follow-up of Columbia, MO Serum Bank Participants
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-09-09A Randomized Prospective Trail of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Recurrent Ovarian Cancer Patients With Mutations in Homologous Recombination Repair (HRR) Genes
-
CLINICAL_TRIALS study record update · 2020-09-02MIRRORS: Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
-
CLINICAL_TRIALS study record update · 2020-08-27Phase I/II Trial of Fenretinide/LXS Oral Powder (NSC 374551) Plus Ketoconazole in Recurrent Ovarian Cancer and Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2020-08-27A Phase 1, Open-Label, Multicenter, Multi-Dose Escalation Study of CM-24 (MK-6018) as Monotherapy and In Combination With Pembrolizumab (MK-3475) in Subjects With Selected Advanced or Recurrent Malignancies
-
CLINICAL_TRIALS study record update · 2020-08-27Correlation Between Grade of Ovarian and Endometrial Carcinoma and the Expression of PD-1/PDL-1.
-
CLINICAL_TRIALS study record update · 2020-08-21A Phase 1 Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2020-08-19Pilot Trial of Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Treatment of Women With Newly Diagnosed, Optimally Cytoreduced Carcinoma of Mullerian Origin
-
CLINICAL_TRIALS study record update · 2020-08-12A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase 2, Multicenter, Open-label, Single-arm Study to Evaluate the Safety and Efficacy of Niraparib in Japanese Patients With Advanced, Relapsed, High-grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received 3 or 4 Previous Chemotherapy Regimens
-
CLINICAL_TRIALS study record update · 2020-08-11Prognostic Value of PDL1 in Ovarian High Grade Serous Carcinoma
-
CLINICAL_TRIALS study record update · 2020-08-10Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-08-07An Exploratory Study of αPD1-MSLN-CAR T Cells Secreting PD-1 Nanobodies for the Treatment of MSLN-positive Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-08-05Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2020-07-28A Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Arsenic Trioxide for Injection in Patients With Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
-
CLINICAL_TRIALS study record update · 2020-07-16PREDICT: Prevalence of BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients in the Gulf Region. A Prospective, Multi-centre, Epidemiological Observational Study Designed to Evaluate the Prevalence of BRCA1 and BRCA2 Mutations in Current and Newly Diagnosed Ovarian Cancer Patients Across Different Countries in the Gulf Region. This Study Study Will Also Describe the Epidemiological Features for the Disease for the Enrolled Patients.
-
CLINICAL_TRIALS study record update · 2020-07-15Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU): A Feasibility Study for Treating Recurrent Gynaecological Malignancies
-
CLINICAL_TRIALS study record update · 2020-07-10Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study
-
CLINICAL_TRIALS study record update · 2020-07-08Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
-
CLINICAL_TRIALS study record update · 2020-07-01A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
-
CLINICAL_TRIALS study record update · 2020-06-30Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation